Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Smoking and risk of treatment-induced neutralizing antibodies to interferon β-1a.
Serum levels of brain-derived neurotrophic factor (BNDF) in multiple sclerosis patients with Trichuris suis ova therapy.
Effects of Intermittent Versus Continuous Walking on Distance Walked and Fatigue in Persons With Multiple Sclerosis: A Randomized Crossover Trial.
Time-efficient, high-resolution, whole brain three-dimensional macromolecular proton fraction mapping.
Prevalence of neurological conditions across the continuum of care based on interRAI assessments.
AKP-11 - A Novel S1P1 Agonist with Favorable Safety Profile Attenuates Experimental Autoimmune Encephalomyelitis in Rat Model of Multiple Sclerosis.
Screening for inhibitors of microglia to reduce neuroinflammation.
Toll like receptors: a new hope on the horizon to treat multiple sclerosis.
A cohort study of Han Chinese MFN2-related Charcot-Marie-Tooth 2A.
Laparoscopic appendectomy in a pediatric patient with type 1 Charcot-Marie-Tooth disease.
Intraoperative smile in a multiple sclerosis patient with medication-refractory tremor.
[Driving ability with multiple sclerosis.]
Neurorehabilitation for Multiple Sclerosis Patients with Emotional Dysfunctions.
Betulinic acid regulates generation of neuroinflammatory mediators responsible for tissue destruction in multiple sclerosis in vitro.
Microbial view of central nervous system autoimmunity.
A MS-lesion pattern discrimination plot based on geostatistics.
Do not judge a cell by its cover-diversity of CNS resident, adjoining and infiltrating myeloid cells in inflammation.
Glutamate Release Machinery Is Altered in the Frontal Cortex of Rats with Experimental Autoimmune Encephalomyelitis.
Treatment-related progressive multifocal leukoencephalopathy: current understanding and future steps.
Regional regulation of glutamate signaling during cuprizone-induced demyelination in the brain.
Vitamin D and the central nervous system.
Noise in multiple sclerosis: unwanted and necessary.
Resolution of central nervous system astrocytic and endothelial sources of CCL2 gene expression during evolving neuroinflammation.
Neuromyelitis optica in a Ugandan woman: a case report.
A forgotten aspect of the NICE reference case: an observational study of the health related quality of life impact on caregivers of people with multiple sclerosis.
Pages
« first
‹ previous
…
446
447
448
449
450
451
452
453
454
…
next ›
last »